Author

Kalliopi Foteinogiannopoulou

FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES
FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Kalliopi Foteinogiannopoulou  et al.

EFFECTS OF COVID-19 ON EMPLOYMENT IN IBD PATIENTS
EFFECTS OF COVID-19 ON EMPLOYMENT IN IBD PATIENTS

Kalliopi Foteinogiannopoulou  et al.

MENTAL HEALTH, WORK PRESENTEEISM AND EXERCISE IN IBD PATIENTS
MENTAL HEALTH, WORK PRESENTEEISM AND EXERCISE IN IBD PATIENTS

Kalliopi Foteinogiannopoulou  et al.

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

Kalliopi Foteinogiannopoulou  et al.

THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB
THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB

Kalliopi Foteinogiannopoulou  et al.

PRELIMINARY DATA ON THE EFFICACY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN A 'REAL-WORLD' CLINICAL SETTING
PRELIMINARY DATA ON THE EFFICACY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN A 'REAL-WORLD' CLINICAL SETTING

Kalliopi Foteinogiannopoulou  et al.

PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY
PREGNANCY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE DATA FROM A GREEK NATIONAL REGISTRY

Kalliopi Foteinogiannopoulou  et al.

Item 1 - 7 / 7
1